JVM Co

JVM Co ROE

The Return on Equity (ROE) of JVM Co (054950.KQ) as of Nov 3, 2026 is 12.12 %. In the previous year, Return on Equity (ROE) was 14.26 % — a change of -14.99% (lower).

ROE

12.12 %

YoY

-14.99%

Last updated:

In 2025, JVM Co's return on equity (ROE) was 12.12 %, a -14.99% increase from the 14.26 % ROE in the previous year.

The JVM Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
6.62 KRW
Jan 1, 2019
4.69 KRW
Jan 1, 2020
7.60 KRW
Jan 1, 2021
6.24 KRW
Jan 1, 2022
9.96 KRW
Jan 1, 2023
14.62 KRW
Jan 1, 2024
14.26 KRW
Jan 1, 2025
12.12 KRW
The JVM Co ROE history
YEARROEYoY
12.12 %-14.99%
14.26 %-2.50%
14.62 %+46.73%
9.96 %+59.75%
6.24 %-17.94%
7.60 %+62.01%
4.69 %-29.16%
6.62 %-29.98%
9.46 %-4.39%
9.89 %+99.00%
4.97 %-51.38%
10.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding JVM Co's Return on Equity (ROE)

JVM Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing JVM Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

JVM Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in JVM Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about JVM Co stock

Return on Equity (ROE) of JVM Co is 12.12 % in 2025.

Return on Equity (ROE) of JVM Co changed from 14.26 % to 12.12 %, representing a -14.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) JVM Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — JVM Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — JVM Co